Form 4: UnitedHealth Group Director Charles D. Baker Reports Acquisition of Common Stock

Sentiment:

SEC Form 4 Filing


Director Charles D. Baker reports acquiring 2 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.

Summary

  • On September 24, 2024, Charles D. Baker, a director of UnitedHealth Group, acquired 2 shares of common stock.
  • The acquisition was a result of dividend equivalents paid on vested deferred stock units.
  • The price per share was $0.
  • The transaction was reported on September 26, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing is a routine disclosure of a transaction related to dividend equivalents.

Positives

  • The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This specific transaction is related to dividend equivalents, which are common in deferred stock unit programs.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders.

Key Dates

DateDescription
09/24/2024Date of transaction: Charles D. Baker acquired 2 shares of common stock.
09/26/2024Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.